Home › Funds › TRAPHAGEN INVESTMENT ADVISORS LLC › AVUS

TRAPHAGEN INVESTMENT ADVISORS LLC position in AVUS

AMERICAN CENTY ETF TR

TRAPHAGEN INVESTMENT ADVISORS LLC reported holding 936,821 shares of AVUS (AMERICAN CENTY ETF TR) in its Q3 2026 13F filing — a position valued at US$120.0M, representing 8.22% of its reported portfolio and ranking #2 among its reported holdings. TRAPHAGEN INVESTMENT ADVISORS LLC has disclosed AVUS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)936.82K sh
Reported value held$120.00M
Portfolio Weight8.22%
First reportedQ3 2023
Last changeReduce
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How TRAPHAGEN INVESTMENT ADVISORS LLC's AVUS position evolved

TRAPHAGEN INVESTMENT ADVISORS LLC first disclosed a stake in AVUS in Q3 2023 at 1,095,600 shares (US$80.3M). The position peaked in Q4 2025 at 1,253,450 shares, worth US$140.1M. Across 13 filings, TRAPHAGEN INVESTMENT ADVISORS LLC increased the stake 9 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 936,821 shares valued at US$120.0M — a reduction of -78,930 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.10M $80.26M New
Q4 2023 1.12M $91.03M Add
Q1 2024 1.13M $101.35M Add
Q2 2024 1.14M $103.14M Add
Q3 2024 1.16M $110.09M Add
Q4 2024 1.17M $113.35M Add
Q1 2025 1.18M $109.06M Add
Q2 2025 1.22M $122.51M Add
Q3 2025 1.23M $134.07M Add
Q4 2025 1.25M $140.11M Add
Q1 2026 1.05M $117.16M Reduce
Q2 2026 1.02M $130.10M Reduce
Q3 2026 936.82K $120.00M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVUS and 13F data

AVUS (AMERICAN CENTY ETF TR) is a company whose sector is not yet classified in our data. 48 other funds we track also report a position in AVUS — the largest reported positions include HB Wealth Management, LLC (US$771.9M), AMERICAN CENTURY COMPANIES INC (US$582.7M), Oak Root LLC (US$372.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVUS

All AVUS fund holders →

FAQ

How long has TRAPHAGEN INVESTMENT ADVISORS LLC held AVUS?

TRAPHAGEN INVESTMENT ADVISORS LLC has disclosed AVUS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TRAPHAGEN INVESTMENT ADVISORS LLC's current position in AVUS?

As of Q3 2026, TRAPHAGEN INVESTMENT ADVISORS LLC holds 936.82K shares of AVUS (AMERICAN CENTY ETF TR), valued at $120.00M, representing 8.22% of its reported portfolio and ranking #2.

Has TRAPHAGEN INVESTMENT ADVISORS LLC been buying or selling AVUS?

In the latest 13F filing (Q3 2026), TRAPHAGEN INVESTMENT ADVISORS LLC reduced its position in AVUS. The position peaked in Q4 2025 at 1.25M shares.

Which other funds hold AVUS?

Other major institutional holders of AVUS include HB Wealth Management, LLC, AMERICAN CENTURY COMPANIES INC, Oak Root LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.